Barinthus Biotherapeutics plc (NASDAQ: BRNS) Stock Information | RedChip

Barinthus Biotherapeutics plc (NASDAQ: BRNS) Listen to this Section


$1.32
N/A ( 0% ) 26.3K

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.

Market Data


Open


$1.32

Previous close


$1.32

Volume


26.3K

Market cap


$51.25M

Day range


$1.27 - $1.35

52 week range


$1.21 - $5.00

Insider Ownership Transactions

Total Amount Purchased: -957,743.00 | $ -1,264,220.76

Date Type Amount Purchased Purchaser
2024-06-18 Sale -195166.00 Hooftman Leon
2024-05-14 Sale -19516.00 DAWES KAREN A
2024-05-14 Sale -19516.00 Scheeren Joseph
2024-05-14 Sale -19516.00 Phillips Anne M.
2024-05-14 Sale -19516.00 Hammacher Alex
2024-05-14 Sale -19516.00 Morgon Pierre A.
2024-05-14 Sale -19516.00 Wright Robin
2024-01-04 Sale -105000.00 Pelletier Nadege
2024-01-04 Sale -96500.00 Griffiths Graham
2024-01-04 Sale -443981.00 Enright William

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 75 Aug 08, 2024
8-k 8K-related 17 Aug 08, 2024
3 Insider transactions 2 Jun 18, 2024
4 Insider transactions 1 Jun 18, 2024
8-k 8K-related 14 Jun 12, 2024
8-k 8K-related 57 Jun 06, 2024
8-k 8K-related 14 May 15, 2024
4 Insider transactions 1 May 14, 2024
4 Insider transactions 1 May 14, 2024
4 Insider transactions 1 May 14, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.